Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05296798 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) |
| First Submitted : | March 23, 2022 |
| First Submitted that Met QC Criteria : | March 23, 2022 |
| First Posted : | March 25, 2022 |
| Last Update Submitted that Met QC Criteria : | April 29, 2024 |
| Last Update Posted : | April 30, 2024 |